UCI researchers uncover new underlying factor of seizures

University of California, Irvine researchers with the School of Medicine have identified the mechanism by which valproic acid controls epileptic seizures, and by doing so, also revealed an underlying factor of seizures.

Valproic acid is widely used to treat various types of seizure disorders, but to this point, the cellular mechanism affected by its anticonvulsant properties were not well understood.

Dr. Naoto Hoshi, an associate professor of pharmacology and physiology & biophysics, and colleagues discovered that valproic acid preserved the M-current during seizures. The M-current is mediated through cellular potassium channels and is important for the proper firing of neuronal signals.

The UCI team also uncovered that during seizures, the M-current is suppressed, which contributes to neuronal hyperexcitability. This underlying factor, Hoshi said, contributes to our understanding of seizures and points to the creation of new, more effective drugs that carry fewer side effects.

Valproic acid is also used to treat manic episodes related to bipolar disorder (manic depression) and to prevent migraine headaches, but the drug is linked to liver damage, birth defects and psychiatric side-effects.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long-COVID lingers in children